a developer of drugs for fungal infection
Industry Biotechnology
A.I.dvisor indicates that over the last year, CDTX has been closely correlated with PIRS. These tickers have moved in lockstep 96% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then PIRS could also see price increases.
Ticker / NAME | Correlation To CDTX | 1D Price Change % | ||
---|---|---|---|---|
CDTX | 100% | +4.17% | ||
PIRS - CDTX | 96% Closely correlated | -0.93% | ||
WINT - CDTX | 94% Closely correlated | -6.25% | ||
NBY - CDTX | 93% Closely correlated | +2.04% | ||
NCNA - CDTX | 93% Closely correlated | -1.90% | ||
SNPX - CDTX | 93% Closely correlated | -4.68% | ||
More |
Ticker / NAME | Correlation To CDTX | 1D Price Change % |
---|---|---|
CDTX | 100% | +4.17% |
CDTX (21 stocks) | 16% Poorly correlated | -1.25% |
drugs (254 stocks) | 10% Poorly correlated | -1.67% |
biotechnology (238 stocks) | -6% Poorly correlated | -1.76% |